// App-Quantinova.ai

2007 : Transcriptional regulatory program controlled by the oncogenic transcription factor LMO1 in neuroblastoma

Researchers

Presenter

  • Takaomi Sanda

Principal Investigators

  • Koshi Akahanse

  • Brian J. Abraham

  • Nina Weichert

  • Adam Durbin

  • Lars Anders

  • Shi Hao Tan

  • Alice Wei Yee Yam

  • Lee N. Lawton

  • Richard A. Young

  • John M. Maris

  • A Thomas Look

Medical Centers

  • Cancer Science Institute, Singapore, Singapore, Singapore

  • Dana-Farber Cancer Institute, Boston, MA

  • Whitehead Institute for Biomedical Research and MIT, Cambridge, MA

  • Children's Hospital of Philadelphia, Pennsylvania, PA.

Locations

  • United States

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • T-cell acute lymphoblastic leukemia

  • Mismatch repair deficiency

  • Neuroblastoma

  • Solid malignancies

Biomarkers

  • Cyclin dependent kinase 6

  • GATA Binding Protein 3

  • LIM Domain Only 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved